Ratings Creo Medical Group PLC

Equities

CREO

GB00BZ1BLL44

Market Closed - London S.E. 11:35:06 2024-04-26 am EDT 5-day change 1st Jan Change
36.25 GBX 0.00% Intraday chart for Creo Medical Group PLC +4.32% -21.20%

Summary

  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company has insufficient levels of profitability.
  • The company's enterprise value to sales, at 3.26 times its current sales, is high.
  • Revenue estimates are regularly revised downwards for the current and coming years.
  • The overall consensus opinion of analysts has deteriorated sharply over the past four months.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
-21.20% 157M -
+73.17% 12.38B
B-
-18.74% 7.92B
C+
+16.15% 7.2B
C-
+4.81% 5.84B
B
+5.99% 5.07B
D+
+27.07% 4.53B -
-21.67% 3.88B
B-
-40.82% 2.23B
C
+1.49% 2.02B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. CREO Stock
  4. Ratings Creo Medical Group PLC